Taura Naota, Hamasaki Keisuke, Nakao Kazuhiko, Ichikawa Tatsuki, Nishimura Daisuke, Goto Takashi, Fukuta Mariko, Kawashimo Hiroshi, Miyaaki Hisamitsu, Fujimoto Masumi, Kusumoto Kouichiro, Motoyoshi Yasuhide, Shibata Hidetaka, Inokuchi Kaoru, Eguchi Katsumi
The First Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki 852-8501, Japan.
Oncol Rep. 2006 Oct;16(4):837-43.
The incidence of hepatocellular carcinoma (HCC) in Japan has been increasing. The aim of the present study was to analyze epidemiological changes in Japanese HCC patients. A total of 463 patients with HCC diagnosed at our hospital between 1982 and 2001 were recruited for this study. Cohorts of patients with HCC were categorized into intervals of five years. The number of HBV- and HCV-associated HCC cases had decreased and increased in 1987-1991, respectively, and thereafter reached a plateau. The mean age of patients at diagnosis of HCV-associated HCC showed a steady significant increase from 60 to 68 years of age during the period, suggesting that these findings were associated with a shift toward an older-age group that had the highest rate of HCV infection. The mean age of patients with other types of HCC did not significantly change during the period. Since it is known that the prevalence of HCV infection in young Japanese persons is low and that the incidence of HCV infection is very low at present, our findings may indicate that the prevalence of HCC will decline in Japan, an advanced country with regard to HCV-associated HCC, in the near future.
日本肝细胞癌(HCC)的发病率一直在上升。本研究的目的是分析日本HCC患者的流行病学变化。本研究招募了1982年至2001年间在我院诊断为HCC的463例患者。HCC患者队列按五年间隔进行分类。1987 - 1991年期间,HBV相关和HCV相关HCC病例数分别减少和增加,此后达到平稳状态。在此期间,诊断为HCV相关HCC患者的平均年龄从60岁稳步显著增加到68岁,这表明这些发现与向HCV感染率最高的老年人群体转变有关。其他类型HCC患者的平均年龄在此期间没有显著变化。由于已知日本年轻人中HCV感染率较低且目前HCV感染发病率非常低,我们的研究结果可能表明,在日本这个在HCV相关HCC方面处于发达国家行列的国家,HCC的发病率在不久的将来将会下降。